These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1090 related items for PubMed ID: 16932589

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease.
    Stocchi F.
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S68-71. PubMed ID: 20083012
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T.
    J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
    Olanow CW.
    Mov Disord; 2008 Sep; 23 Suppl 3():S613-22. PubMed ID: 18781663
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities.
    Jenner P.
    Mov Disord; 2008 Sep; 23 Suppl 3():S585-98. PubMed ID: 18781676
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of levodopa-induced motor complications.
    Stocchi F, Tagliati M, Olanow CW.
    Mov Disord; 2008 Sep; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Maximizing the benefit:risk ratio of levodopa therapy in Parkinson's disease.
    Gottwald MD.
    Pharmacotherapy; 1999 Nov; 19(11 Pt 2):162S-8S. PubMed ID: 10555944
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Stocchi F.
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S9-S15. PubMed ID: 19131046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.